EUROPE DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • EUROPE DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028

EUROPE DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028

The Europe dermatological therapeutics market is predicted to project a CAGR of 7.56% during the forecast period, 2019-2028. The high prevalence of skin diseases is the most dominating factor stimulating the market growth of the region. Germany, France, Italy, Poland, Belgium, the United Kingdom, Russia, and the rest of Europe, are analyzed in the Europe dermatological therapeutics market growth evaluation.

EUROPE DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028

Europe Dermatological Therapeutics Market by Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, Other Drug Classes) by Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Acne Vulgaris, Other Applications) and by Geography.

Request free sample

The Europe dermatological therapeutics market is predicted to project a CAGR of 7.56% during the forecast period, 2019-2028. The high prevalence of skin diseases is the most dominating factor stimulating the market growth of the region.
Europe Dermatological Therapeutics Market

To know more about this report, request a free sample copy

Germany, France, Italy, Poland, Belgium, the United Kingdom, Russia, and the rest of Europe, are analyzed in the Europe dermatological therapeutics market growth evaluation. The increasing prevalence of skin diseases, enhanced healthcare facilities, and government aid in the form of policies, are factors propelling the growth of the market in the UK. Atopic dermatitis is highly pervasive in the UK, according to a study published by Michel J Cork. Another study on the epidemiology of rosacea conducted in 2018, determines that the incidence rate of rosacea was 1.65 per 1000 person-years. Also, several institutes are prioritizing on spreading awareness about skin diseases. For example, a national campaign called Sun Awareness is undertaken by the British Association of Dermatologists (BAD). It also includes national Sun Awareness Week every year in the month of May. Such initiatives are projected to increase awareness about various skin conditions, which will be further beneficial for the growth of the market. In Italy, stats by the Health Metrics and Evaluation (IHME) state that 4.7% of the population was diagnosed with dermatitis in 2017. The country entails a well-developed healthcare system. It is also ranked among the top 10 countries that provide quality health services, by the WHO. The growing aging population, rising skin diseases, and well-developed healthcare infrastructure, are estimated to propel the market growth in Italy.

GlaxoSmithKline PLC is a healthcare company that manufactures and sells pharmaceuticals and vaccines. The company supplies medicines for several therapeutic areas like dermatology, immune-inflammation, and anti-bacterial. One of its products includes Sorilux, which is used for the treatment of plaque psoriasis. The company has its presence in the US, UK, and Europe. It has its headquarters in Brentford, Middlesex, UK.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • RISING LOAD OF DERMATOLOGY DISEASES
      • RISE IN AWARENESS LEVELS OF DISEASE PROGRESSION AND ORIGIN
    •    KEY RESTRAINTS
      • SEVERE SIDE EFFECTS OF CERTAIN CLASSES OF THERAPEUTIC DRUGS
  1. KEY ANALYTICS
    • KEY INVESTMENT INSIGHTS
    •    PORTER’S FIVE FORCE ANALYSIS
      • BUYER POWER
      • SUPPLIER POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY DRUG CLASS
    • ANTI-INFECTIVES
    • CORTICOSTEROIDS
    • ANTI-ACNE
    • CALCINEURIN INHIBITORS
    • RETINOIDS
    • OTHER DRUG CLASSES
  3. MARKET BY APPLICATION
    • ALOPECIA
    • HERPES
    • PSORIASIS
    • ROSACEA
    • ATOPIC DERMATITIS
    • ACNE VULGARIS
    • OTHER APPLICATIONS
  4. GEOGRAPHICAL ANALYSIS
    •    EUROPE
      • UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
  1. COMPANY PROFILES
    • ABBVIE INC
    • ALLERGAN INC
    • ALMIRAL
    • AMGEN INC
    • BAUSCH HEALTH COMPANIES INC
    • GALDERMA
    • GLAXOSMITHKLINE PLC
    • JOHNSON & JOHNSON
    • NOVARTIS AG
    • PFIZER INC
    • AGI DERMATICS
    • LEO PHARMA A/S
    • MERCK KGAA

TABLE LIST

TABLE 1: MARKET SNAPSHOT – DERMATOLOGICAL THERAPEUTICS

TABLE 2: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)

TABLE 3: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028 (IN $ BILLION)

TABLE 4: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)

TABLE 5: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY, APPLICATION, FORECAST YEARS, 2019-2028 (IN $ BILLION)

TABLE 6: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)

TABLE 7: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)

FIGURE LIST

FIGURE 1: KEY INVESTMENT INSIGHTS

FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, GROWTH POTENTIAL, BY DRUG CLASS, IN 2019

FIGURE 6: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $ BILLION)

FIGURE 7: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $ BILLION)

FIGURE 8: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)

FIGURE 9: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $ BILLION)

FIGURE 10: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)

FIGURE 11: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $ BILLION)

FIGURE 12: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019

FIGURE 13: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)

FIGURE 14: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)

FIGURE 15: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $ BILLION)

FIGURE 16: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $ BILLION)

FIGURE 17: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS, 2019-2028 (IN $ BILLION)

FIGURE 18: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $ BILLION)

FIGURE 19: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ BILLION)

FIGURE 20: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 21: UNITED KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 22: GERMANY DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 23: FRANCE DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 24: ITALY DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 25: RUSSIA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 26: BELGIUM DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 27: POLAND DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 28: REST OF EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

  1. GEOGRAPHICAL ANALYSIS
    •    EUROPE
      • UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
  1. MARKET BY DRUG CLASS
    • ANTI-INFECTIVES
    • CORTICOSTEROIDS
    • ANTI-ACNE
    • CALCINEURIN INHIBITORS
    • RETINOIDS
    • OTHER DRUG CLASSES
  2. MARKET BY APPLICATION
    • ALOPECIA
    • HERPES
    • PSORIASIS
    • ROSACEA
    • ATOPIC DERMATITIS
    • ACNE VULGARIS
    • OTHER APPLICATIONS

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now